Veeva Systems is a cloud software, data, and services company focused exclusively on the life sciences industry, serving pharmaceutical, biotech, and medical device companies. Veeva operates across two core areas: R&D and commercial. On the R&D side, Veeva provides tools for clinical trial management, regulatory submissions, and drug safety — including eTMF, CTMS, EDC, and safety reporting systems used by sponsors and CROs. On the commercial side, Veeva's core product is a CRM system used by pharma sales reps to manage engagement with HCPs, supported by a growing suite of add-ons covering marketing automation, patient services, and promotional content management. Veeva also sells data products, including HCP reference data (OpenData) and pharma marketing analytics (Crossix), which helps pharma brands measure digital ad spend. Veeva sells to 1,552 customers, from the world's largest pharma companies to small biotechs, primarily through a direct sales force. The business model is predominantly subscription-based, with customers paying annual fees for cloud applications and data products. Veeva grows by adding new customers and expanding within existing accounts as customers adopt more products over time. Large R&D deals are often multi-year ramp contracts. Professional services and consulting round out the revenue mix. Veeva holds near-monopoly positions in several R&D product categories, and is currently executing a multi-year migration of its CRM base from a legacy Salesforce-based product to its own Vault CRM platform, while embedding AI agents across its product suite.